• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Wellness

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

byNancy LuandAvneesh Bhangu
October 22, 2021
in Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This quantitative study found that transgender Veterans Health Administration (VA) patients were more likely to use certain drugs than cisgender VA patients.

2. Opioid and sedative use disorder did not differ significantly between transgender and cisgender VA patients.

Evidence Rating Level: 2 (Good)

Drug use disorders in the United States (US) are a major problem, especially among vulnerable groups. One example of a vulnerable group is transgender people, defined as people whose genders are different from those assigned at birth. Few studies compare substance use disorder prevalence rates between transgender and cisgender patients, and most of these studies have been small. As the largest national provider of substance use treatment, the US Veterans Health Administration (VA) provides a large dataset to study this important question.

This retrospective quantitative study was a secondary analysis of electronic health record data from the VA Corporate Data Warehouse, which is a parent study examining patterns of alcohol use among transgender versus cisgender VA outpatients from October 1st, 2009 to July 31st,2017. Patients were included if they had a documented alcohol use disorder (n=8,872,793). Patients were excluded if they did not answer all study questions. The measured outcome variables were the documented drug use disorder diagnoses.

Amongst 8,872,793 included patients, 8619 were transgender. From the analyses, the research demonstrated that transgender VA patients were more likely to have amphetamine, cocaine, and cannabis use disorders compared to cisgender patients, but were equally likely to have opioid and sedative use disorders. Furthermore, there was no significant association with having a mental health condition. This study did have its limitations including possible misclassification of certain transgender patients as well as not distinguishing between men and women. Despite these limitations, this study furthered our understanding of struggles and barriers transgender people may face in regards to substance use disorders.

Click to read the study in Journal of Addiction Medicine

RELATED REPORTS

United States medical cannabis registration increased significantly between 2016 and 2020

Post-operative opioids at discharge increase adverse events without improving pain management

Medical cannabis provides little improvement to sleep in chronic pain patients

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: amphetaminecannabiscisgendercocaineopioidtransgenderveteran
Previous Post

Top 10 TV Shows to Binge Watch During Lockdown

Next Post

#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

RelatedReports

Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

United States medical cannabis registration increased significantly between 2016 and 2020

June 29, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Chronic Disease

Post-operative opioids at discharge increase adverse events without improving pain management

June 28, 2022
Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Medical cannabis provides little improvement to sleep in chronic pain patients

May 27, 2022
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Wellness

Wellness Check: Sleep

May 26, 2022
Next Post
#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

Coronavirus: Warning over easing lockdown measures too quickly

For Some Trump Voters, Coronavirus Was The Last Straw

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.